They do not contain live bacteria, they do not colonize the gut, and they do not produce postbiotic metabolites like P9 or butyrate
As a peptide molecule, retatrutide is susceptible to thermal degradation a process whereby elevated temperatures can accelerate breakdown of the amino acid chain, potentially reducing or eliminating pharmacological activity
Semaglutide reduces body weight by around 14% on average, while tirzepatide in clinical trials has shown up to 20% weight loss on average
These medications have established Novo as the dominant player, especially considering its broad indications for both type 2 diabetes and obesity
Retatrutide may become a staple of our obesity treatment arsenal
Though they work similarly, Ozempic is a medication used to enhance the bodys GLP-1 activity, making it more effective at reducing appetite and promoting weight loss